US Patent Issued to Wylder Nation Foundation on Dec. 2 for "Compositions and methods for activating signaling through the CB1 cannabinoid receptor for treating and preventing diseases and disorders characterized by abnormal cellular accumulation of sphingolipids such as sphingomyelin" (Arizona Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,117, issued on Dec. 2, was assigned to Wylder Nation Foundation (Scottsdale, Ariz.).

"Compositions and methods for activating signaling through the CB1 cannabinoid receptor for treating and preventing diseases and disorders characterized by abnormal cellular accumulation of sphingolipids such as sphingomyelin" was invented by Maria Dolores Ledesma (Scottsdale, Ariz.), Adrian Bartoll (Scottsdale, Ariz.) and Edward H. Schuchman (Scottsdale, Ariz.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, inter alia, compositions and methods for using CB1 cannabinoid receptor agonists, or other compounds capable of increasing endocan...